Objectives: To test whether or not the use of a xenogeneic block loaded with recombinant human bone morphogenetic protein-2 (rhBMP-2) results in different bone quantity and quality compared to an autogenous bone block.
| INTRODUCTION
A variety of surgical techniques and biomaterials have been described in the literature to enhance deficient alveolar bone volume prior to implant placement: autogenous bone grafts, distraction osteogenesis, bone splitting and guided bone regeneration (GBR) (Buser, Dula, Belser, Hirt, & Berthold, 1993; Cordaro, Amade, & Cordaro, 2002; Milinkovic & Cordaro, 2014; Oda, Sawaki, & Ueda, 2000) . Among these, GBR is one of the best documented methods reporting high success rates for bone regeneration Hammerle & Karring, 1998 ) and implant survival rates in augmented bone (Clementini, Morlupi, Canullo, Agrestini, & Barlattani, 2012; Nevins, Mellonig, Clem, Reiser, & Buser, 1998) .
Autogenous bone grafts are considered to be the gold standard for GBR using a staged approach with subsequent implant placement (von Arx et al., 2001; Nevins & Mellonig, 1994) . The addition of deproteinized bovine bone mineral (DBBM) particles to cover the block and fill voids has shown to be effective in terms of clinical and histologic results (von Arx & Buser, 2006; Proussaefs & Lozada, 2003; Proussaefs, Lozada, & Rohrer, 2002) and does further decrease the amount of resorption (Cordaro, Torsello, Morcavallo, & di Torresanto, 2011; Maiorana, Beretta, Salina, & Santoro, 2005; Wiltfang et al., 2014) .
The use of a second surgical site is reported to be a major drawback when using autogenous bone blocks. Complications including altered sensation of teeth, neurosensory disturbances, wound dehiscence and infections have been described (von Arx, Hafliger, & Chappuis, 2005; Nkenke, Schultze-Mosgau, Radespiel-Troger, Kloss, & Neukam, 2001 ).
In order to overcome issues due to the harvesting procedure, research activities were directed towards the development of biomaterials. Clinical studies demonstrated that the use of a xenogeneic grafting material in combination with a collagen membrane was an effective treatment modality for staged horizontal bone augmentation (Hammerle, Jung, Yaman, & Lang, 2008; Norton, Odell, Thompson, & Cook, 2003) . In addition, research has focused on the use of bioactive molecules to induce localized bone formation (Reddi, Wientroub, & Muthukumaran, 1987; Urist, 1965) . Among more than 30 identified bone morphogenetic proteins (BMP), only a small number (BMP-2, BMP-4, BMP-7, BMP-9) appeared to have osteoinductive functions (Cheng et al., 2003) .
Various combinations of recombinant human bone morphogenetic protein-2 (rhBMP-2), the most potential growth factor and carrier materials have been evaluated in the past (Jung, Thoma, & Hammerle, 2008; Schliephake, 2015) . Early attempts used an absorbable collagen sponge to serve as a carrier for rhBMP-2. This combination, however, failed to demonstrate adequate mechanical stability (Barboza et al., 2000) . In a more recent pre-clinical study, rhBMP-2 was combined with a printed PCL/PLGA/β-TCP membrane. Statistically significantly more bone formation was found underneath membranes combined with rhBMP-2 (Shim et al., 2014) . Clinically, xenogeneic bone substitute materials are frequently used for various guided bone regeneration procedures. The same materials were also used as carrier materials for biologic mediators, the first time in combination with rhBMP-7 (Terheyden, Jepsen, Moller, Tucker, & Rueger, 1999) . The intent, at that time, was to provide an osteoconductive carrier serving to provide mechanical stability and to induce cell infiltration. A randomized, controlled clinical study demonstrated an enhanced process of bone regeneration and an increased graft to bone contact for rhB-MP-2 combined with a xenogeneic bone substitute materials . Excellent radiological outcomes were reported during a 3-and 5-year follow-up (Jung et al., 2009 ).
Currently, no scientific data exist with respect to clinical studies comparing the gold standard (autogenous bone graft plus collagen membrane) with the promising combination of a xenogeneic bone graft loaded with rhBMP-2 for localized ridge augmentation.
The aim of this study was therefore to test whether or not, for primary bone augmentation, the use of a xenogeneic block loaded with rhBMP-2 results in different bone quantity (clinically) and quality (histologically) compared to an autogenous bone block and to evaluate
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Clinical relevance
Scientific rationale for the study: For primary bone augmentation, the use of autogenous block grafts is considered to be the gold standard for GBR. This approach is associated with an increased patient morbidity. To avoid this limitation, a form-stable xenogeneic block graft loaded with an osteoinductive growth factor recombinant human bone morphogenetic protein-2 (rhBMP-2) was proposed as a treatment alternative.
Principal findings: Four months after ridge augmentation, implant placement was possible in all patients, and the obtained ridge width was comparable in both groups.
Patient-reported outcome measures did not reveal any significant differences between the groups except for pain during surgery at the recipient site (in favour of the test group).
Histologically, a higher amount of mineralized tissue was observed for the control group at 4 months.
Practical implications:
The combination of a xenogeneic block loaded with rhBMP-2 might be an alternative treatment option for lateral ridge augmentation, offering sufficient bone regeneration to place dental implants four months after primary augmentation. patient morbidity following the surgical interventions with the two treatment modalities.
| MATERIALS AND METHODS
This two-centre study was designed as an exploratory, prospective, randomized, controlled clinical trial. The local ethical committees of Zurich and Graz approved all procedures and materials prior to the start of the investigation. Informed consent was obtained from all participating patients. Twenty-four patients were scheduled to be included and to be consecutively treated at the Clinic of Fixed and Removable Prosthodontics and Dental Material Science, University of Zurich, Zurich, Switzerland (centre 1), and at the Department of Oral Surgery and Radiology, School of Dentistry, Medical University Graz, Graz, Austria (centre 2). The sample size of this study was determined based on a previous clinical study using 11 patients in a split-mouth design using the same growth factor and xenogeneic bone substitute material . As no clinical data were available for the same combination of materials for primary augmentation, the number of patients was increased to 24 (non-splitmouth design), but considered to be of exploratory nature.
| Patients
A total of 24 partially edentulous patients in need of implant therapy and presenting an insufficient bone volume (horizontal ridge width<5 mm) to allow placing a standard diameter implant, which is defect-free, in a prosthetically ideal position were included. An in vitro investigation revealed that in combination with this carrier, the concentration of rhBMP-2 is reduced by 30% up to day 5 (data on file).
ii) an autogenous bone block combined with DBBM particles (Bio-Oss Granules ® , Geistlich Pharma AG, Wolhusen, Switzerland) (control).
| Surgical procedure
Prior to the start of the surgery, patients rinsed with 0.2% of chlorhex- 
| Recipient site preparation
A paracrestal incision placing the line of incision towards the palatal aspect of the ridge was applied. Oblique releasing incisions were used to allow for a wide flap basis as well as sufficient access to the defective ridge area. Any soft tissues remaining on the crest were meticulously removed, and the ridge width was measured. The cortical bone plate was perforated at numerous locations.
| Donor site preparation (control only)
Depending on the size of the ridge defect (recipient site) and the donor site anatomy, the blocks were harvested from the symphysis or the retromolar area. A mucoperiosteal flap was elevated at the donor site, followed by preparation with a fissure bur or a piezo device and careful block graft mobilization (von Arx & Buser, 2006) ( Figure 2b ).
| Ridge augmentation at recipient site
In the test group, rhBMP-2 was re-suspended in sterile ultra-purified water according to the manufacturer's protocol. The DBBM block was then moistened for 15 min with 1.2 ml rhBMP-2 (InductOs ® , rhBMP-growth factor per ccm of DBBM block ( Figure 1b ). The xenogeneic block was shaped with a blade and adapted to the defect. In the control group, the blocks were adapted to the defect site morphology.
With a small drill, holes for fixation (GBR-System, Institut Straumann AG, Basel, Switzerland) were prepared, and the bone blocks were immobilized with one or two screws ( Figure 2c ). Subsequently, a layer of xenogeneic bone particles was applied to cover the autogenous bone and to fill up voids in both groups.
The obtained ridge width was again measured before application of the membrane. In both groups, the collagen membrane was trimmed to extend the augmented area 2-3 mm onto the intact bony borders of the defect. The membrane was fixated using resorbable fixation pins (ZorbTac ® , Imtec, 3MEspe, Oberursel, Germany).
Tension-free wound closure was obtained through releasing incisions in the periosteum. A horizontal mattress suture and further single in-
Flagstaff, AZ, USA) were placed intending a primary wound closure in both groups.
All patients received analgesic and anti-inflammatory medications (Ponstan ® ) and were instructed to rinse with chlorhexidine (Meridol ® Perio Chlorhexidin Lösung 0.2%). A second dose of penicillin (Clamoxyl ® ) (1.5 g) was prescribed 6 hr after the first dose.
Subsequently, penicillin was given for 7 consecutive days (2.25 g per day). Temporary removable partial dentures were carefully checked and adapted if necessary to avoid trauma to the surgical area.
Between 7 and 9 days following augmentation surgery, all sutures were removed. were performed in case of dehiscence or fenestration defects at the implants. Flaps were then adapted to allow either for a transmucosal or for a submerged healing of the implant (data not reported here).
| Re-entry at 4 months

| Processing of histologic samples
The specimens obtained at the re-entry 4 months after augmentation were fixed with 4% formalin for at least 48 hr. Specimens within 
| Measurements
In patients with more than one prospective implant site, the most mesial site was chosen for analysis. In case there were two most mesial implant sites, one was chosen randomly. The respective time points of all measurements are shown in Figure 4 .
| Clinical measurements
The ridge width was measured by means of a calliper to assess the oro-facial bone width to the nearest millimetre at the prospective implant site after flap elevation, after augmentation and at 4 months.
Furthermore, plaque index (PI), probing depth (PD), bleeding on probing (BoP) and the width of the keratinized mucosa (KM) at neighbouring teeth were assessed prior to augmentation surgery and at 4 months. The status of the soft tissues was rated as normal (1), red (2), swollen (3) or dehiscence (4) on a scale from 1 to 4 at suture removal and at 4 months. Anamnestic information in terms of sensitivity was reported at suture removal and at 4 months and was rated as normal (1) or disturbed/not present (0).
| Patient-reported outcome measures (PROMs)
A total of seven questions were evaluated at suture removal using a visual analogue scale (VAS score; VAS 0-100, 100 reflecting the highest morbidity). Pain during surgery, pain and swelling in the week following ridge augmentation until suture removal were assessed for the recipient and the donor site (control only). Patients were further asked about their willingness to repeat the treatment. In addition, the use of pain medication and the number of days pain medication was taken were reported at the same time point.
| Histomorphometric assessment
The histomorphometric analysis was performed by means of a software program (LAS V4.3, Leica Microsystems, Wetzlar, Germany).
Within the selected region of interest (ROI), the percentage of bone, bone substitute material, soft tissue and background was analysed. 
| RESULTS
In one patient included, an autogenous bone block was exposed 6 days after surgery. The block was removed after 21 days, as antiseptic treatment was not successful. As the patient refused to repeat the intervention, he was excluded from the study and was replaced by an additional patient according to the study protocol, also receiving an autogenous bone block. The subsequent 24 patients were con- The difference between the two centres was not statistically significant for both groups and all three time points (p > .1612). All descriptive measures are given in Table 1 , and ridge width measurements of every single patient are given in the Appendix S1. and 3.0 mm (Q1 = 2.0; Q3 = 3.8, control) at 4 months. The median soft tissue condition was rated 3.0 (Q1 = 1.8; Q3 = 3.0) in the test group (Figure 3b,c) .
All descriptive results are given in Tables 1 and 2 .
| DISCUSSION
The present two-centre randomized controlled trial demonstrated the following: i) both treatment modalities (rhBMP-2 loaded on a xenogeneic block graft and an autogenous bone block) rendered sufficient ridge width to place dental implants, ii) between postsurgery and the 4-month follow-up, less than 0.6 mm of ridge width was lost, iii) PROMs were not statistically significantly different from the control group for the majority of the outcome measures, and iv) the tissue obtained through biopsies at 4 months consisted of 50% (test) and 75%
(control) mineralized tissue.
A plethora of pre-clinical and clinical studies evaluated rhBMP-2 with various combinations of scaffold materials (Agrawal & Sinha, 2016 ). The collagen sponge, which is probably the first and most frequently investigated carrier, appears to lack space maintenance for primary augmentation without the addition of a space-maintaining device (Barboza et al., 2000) . Consequently, promising results were reported for combinations of a collagen sponge loaded with rhBMP-2 with a titanium mesh (de Freitas et al., 2013 (de Freitas et al., , 2016 Ribeiro Filho et al., 2015) . A combination of anorganic bovine bone loaded with rhB-MP-2 and a titanium mesh leads to comparable results, based on a retrospective case series (Butura & Galindo, 2014) . Apart from spacemaintaining membranes, bone substitute materials might serve as form-stable carrier materials. More than a decade ago, rhBMP-2 was combined with a xenogeneic bone substitute material for localized bone regeneration at buccal dehiscence defects. That clinical study demonstrated more favourable results when rhBMP-2 was added to xenogeneic granules compared to a control group without the growth factor . These data were later supported by a series of pre-clinical studies, all demonstrating the high potential of this F I G U R E 5 Patient-reported outcome measures from a questionnaire with seven questions answered on a visual analogue scale with a score from 0 to 100, with 100 reflecting the highest morbidity. The data are presented as a mean with standard deviation. Pain during surgery at the recipient site was statistically significantly different (p < 0.05). The willingness to repeat the treatment was generally high. Control, autologous bone block; test, xenogeneic block with rhBMP-II combination for localized bone regeneration (Gruber et al., 2014; Schwarz et al., 2009; Thoma, Kruse, Ghayor, Jung, & Weber, 2015; Yon et al., 2015) . Due to the size of the defect and thereby a further need of stability of the augmentation in the present study, the DBBM block was used. These blocks have shown a rather poor ingrowth of bone in a pre-clinical study, but appeared to be efficient in keeping the augmented dimension (Benic et al., 2016) . Apart from this, a clinical case series demonstrated successful primary augmentation using the same DBBM block material. As a disadvantage, that protocol required a relatively long healing time . Predominantly, the latter study indicated that such DBBM blocks can indeed serve for primary augmentation. To reduce the healing time, DBBM was combined with the growth factor rhBMP-2.
Narrow ridges presenting an insufficient width to place dental implants are common in daily practice. The use of autogenous tissue is considered to be the gold standard to regenerate the missing volume and to allow for dental implant placement. The combined use with DBBM particles in the control group can be seen as a confounder on the one hand, but the beneficial effect in terms of a slower graft resorption is documented (Cordaro et al., 2011; Maiorana et al., 2005; Wiltfang et al., 2014) . Thus, the test group was compared with the best treatment modality available. From a clinical point of view, the ability to place dental implants following a healing period after primary bone augmentation is considered as the main goal of the therapy (Butura & Galindo, 2014; Marx, Armentano, Olavarria, & Samaniego, 2013; Misch, Jensen, Pikos, & Malmquist, 2015; Ribeiro Filho et al., 2015) . This was underlined by the outcomes of the present study, demonstrating that both treatment modalities were successful and allowed placing dental implants in all sites (except in one patient where an autogenous bone block failed).
When comparing economic aspects, the test group can be considered advantageous in terms of surgical efforts as there is no harvesting procedure. In contrast, there are more expenses for materials, that is the DBBM block and the growth factor. An 8-ml dose costs 4,500 swiss francs; however, 2 ml was enough to moisten the block, and the volume of one block was sufficient to augment up to 4 neighbouring sites.
None of the two groups was more favourable based on ridge dimensions being similar at the day of augmentation (postsurgery) and at 4 months. The overall increase in ridge width amounted to 4 mm (test) and 5 mm (control). These data are in line with previous clinical studies on primary bone augmentation using autogenous bone blocks or rhBMP-2 in combination with titanium-reinforced porous polyethylene containments (Cordaro et al., 2002; Hart & Bowles, 2012; Monje et al., 2015) . The graft resorption is generally reported to be higher for autogenous bone compared to DBBM (Gultekin, Cansiz, & Borahan, 2016; Jensen, Broggini, Hjorting-Hansen, Schenk, & Buser, 2006 ). In the current study, the resorption rate (ridge width) during the healing phase was relatively low. This might be due to the coverage with DBBM particles of the autogenous graft (Cordaro et al., 2011; Wiltfang et al., 2014) as well as due to the relatively short observation period. The amount of resorption for autogenous grafts is highly variable in the literature and might result in a loss between 5.5 and 22% (Cordaro et al., 2011) but up to 60% (Widmark, Andersson, & Ivanoff, 1997) .
Apart from the main objective to regenerate missing volume, patients' demands increased in the past for therapeutic options associated with less morbidity and less complications. PROMs are frequently used to assess patient morbidity using various scoring systems and questionnaires. In the present study, patient-reported outcome measures included the following: questionnaires using a visual analogue scale (VAS) to assess pain during surgery and postoperative pain, the reported number of days pain medication was used and clinical measurements to evaluate intra-and extra-oral sensitivity. The test group without a second surgical site demonstrated less pain during surgery at the recipient site, a lower number of days that pain medication was taken (2.8 days for test vs.
4.4 days for control) and more sites with an intact intra-oral (91% for test vs. 50% for control) and extra-oral (92% vs. 50%) sensitivity at 4 months. One has to bear in mind, however, that the majority of the assessed PROMs were not significantly different between the two treatment modalities. In terms of swelling, comparable results were reported in both groups. This is quite surprising as previous studies reported a considerable swelling after the use of rhBMP-2 (Edmunds et al., 2014; Marx et al., 2013) . The assessment of PROMs to detect differences between treatment modalities is difficult to achieve for any surgical intervention in the oral cavity. Unfortunately, in the control group, pain and swelling were assessed separately for donor and recipient sites. Due to this fact, no overall pain and swelling rates were possible to calculate, probably resulting in only minor differences between the groups. Previous studies assessing surgical interventions with (autogenous tissue) or without (substitute material) a second surgical site reported similar difficulties to demonstrate significant differences between two or more treatment modalities (McGuire & Nunn, 2005) . It remains questionable if the patients were able to locate the recipient site and distinguish it from the donor site. In addition, there might be an upper limit in terms of how much pain is perceived in the oral cavity. The addition of a further surgical site increased the overall pain perception, but probably not enough to detect substantial differences between the two groups.
Further parameters that might have influenced the unexpectedly low differences were high standard deviations, two centres involved and relatively small area that underwent primary bone augmentation (1-4 sites).
At the day of implant placement, core biopsies were harvested, and the regenerated tissues were analysed. For the autogenous group, a high amount of mineralized tissue (75%) was found. For the combination of rhBMP-2 and the xenogeneic block graft, the amount of mineralized tissue was significantly lower (50%). In a comparable study, biopsies were taken at 6 months compared to present biopsies harvested at 4 months (de Freitas et al., 2016) . The amount of mineralized tissue was similar for the autogenous blocks compared with a collagen sponge loaded with rhBMP-2 under a titanium mesh, again proving the regenerative potential of the growth factor. Moreover, the amount of mineralized tissue obtained for rhBMP-2 combined with DBBM was comparable to previous clinical data on lateral ridge augmentation, with core biopsies taken at the buccal aspect and a rate of mineralized tissue reported to range between 40 and 50% .
The outcomes of the present study and the respective translation into daily practice are to some extent limited by i) a slight imbalance at baseline with larger defects in the control group (borderline significance), ii) difficulties for patients to distinguish between the recipient and donor sites when PROMs were analysed, iii) a limited number of patients (exploratory study without power analysis), iv) a short observation period of 4 months and v) by the fact that the xenogeneic block graft (almost worldwide) and rhBMP-2 (in some countries as a combination with a resorbable collagen sponge; e.g. the United States and Canada) are commercially available, but not worldwide rhBMP-2 and not as a combination product.
| CONCLUSIONS
Both treatment modalities were successful in regenerating bone and increasing the ridge width to allow for dental implant placement at 4 months. PROMs did, in general, not reveal any significant differences between the groups except for pain during surgery at the recipient site (in favour of the test group). Histologically, a higher amount of mineralized tissue was observed for the control group at 4 months.
